Literature DB >> 32417749

Longitudinal flortaucipir ([18F]AV-1451) PET uptake in semantic dementia.

Rene L Utianski1, Hugo Botha2, Jennifer L Whitwell3, Peter R Martin4, Christopher G Schwarz3, Joseph R Duffy2, Heather M Clark2, Anthony J Spychalla3, Matthew L Senjem5, Ronald C Petersen2, David S Knopman2, Clifford R Jack3, Val J Lowe3, Keith A Josephs2.   

Abstract

To assess volume loss and flortaucipir uptake in patients with semantic dementia (SD) over time. Eight SD patients (3 female) underwent clinical evaluations, flortaucipir positron emission tomography, and brain magnetic resonance imaging at 2 visits. Voxel-level comparisons of magnetic resonance imaging gray and white matter volume loss and flortaucipir positron emission tomography uptake were performed in SPM12, comparing SD patients to controls at each visit. T-tests on difference images and paired t-tests of flortaucipir uptake were also performed. At the voxel level, SD patients showed asymmetric, bilateral gray volume loss in the temporal lobes, which, via visual inspection, extended posteriorly at follow-up. White matter loss and flortaucipir uptake were noted in SD patients in the left temporal lobe only, which appeared to extend posteriorly, without involvement of the right hemisphere at follow-up. Longitudinal analyses did not support significant changes in flortaucipir uptake between visits. The biological mechanisms of flortaucipir signal in suspected underlying TAR-DNA binding protein 43 pathology are unknown. A 1-year interval is not sufficient time to demonstrate significant longitudinal flortaucipir uptake changes in SD.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MRI; PET; Primary progressive aphasia; Semantic dementia; Tau

Mesh:

Substances:

Year:  2020        PMID: 32417749      PMCID: PMC7365267          DOI: 10.1016/j.neurobiolaging.2020.04.010

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  45 in total

1.  The selective impairment of semantic memory.

Authors:  E K Warrington
Journal:  Q J Exp Psychol       Date:  1975-11       Impact factor: 2.143

2.  Identification of AV-1451 as a Weak, Nonselective Inhibitor of Monoamine Oxidase.

Authors:  Lindsey R Drake; Jonathan M Pham; Timothy J Desmond; Andrew V Mossine; So Jeong Lee; Michael R Kilbourn; Robert A Koeppe; Allen F Brooks; Peter J H Scott
Journal:  ACS Chem Neurosci       Date:  2019-08-05       Impact factor: 4.418

3.  Distinguishing subtypes in primary progressive aphasia: application of the Sydney language battery.

Authors:  Sharon Savage; Sharpley Hsieh; Felicity Leslie; David Foxe; Olivier Piguet; John R Hodges
Journal:  Dement Geriatr Cogn Disord       Date:  2013-02-28       Impact factor: 2.959

4.  Prevalence of mild cognitive impairment is higher in men. The Mayo Clinic Study of Aging.

Authors:  R C Petersen; R O Roberts; D S Knopman; Y E Geda; R H Cha; V S Pankratz; B F Boeve; E G Tangalos; R J Ivnik; W A Rocca
Journal:  Neurology       Date:  2010-09-07       Impact factor: 9.910

5.  Typical and atypical pathology in primary progressive aphasia variants.

Authors:  Edoardo G Spinelli; Maria Luisa Mandelli; Zachary A Miller; Miguel A Santos-Santos; Stephen M Wilson; Federica Agosta; Lea T Grinberg; Eric J Huang; John Q Trojanowski; Marita Meyer; Maya L Henry; Giancarlo Comi; Gil Rabinovici; Howard J Rosen; Massimo Filippi; Bruce L Miller; William W Seeley; Maria Luisa Gorno-Tempini
Journal:  Ann Neurol       Date:  2017-03-20       Impact factor: 10.422

6.  Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue.

Authors:  Marta Marquié; Marc D Normandin; Charles R Vanderburg; Isabel M Costantino; Elizabeth A Bien; Lisa G Rycyna; William E Klunk; Chester A Mathis; Milos D Ikonomovic; Manik L Debnath; Neil Vasdev; Bradford C Dickerson; Stephen N Gomperts; John H Growdon; Keith A Johnson; Matthew P Frosch; Bradley T Hyman; Teresa Gómez-Isla
Journal:  Ann Neurol       Date:  2015-09-25       Impact factor: 10.422

7.  The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics.

Authors:  Rosebud O Roberts; Yonas E Geda; David S Knopman; Ruth H Cha; V Shane Pankratz; Bradley F Boeve; Robert J Ivnik; Eric G Tangalos; Ronald C Petersen; Walter A Rocca
Journal:  Neuroepidemiology       Date:  2008-02-07       Impact factor: 3.282

8.  Longitudinal tau PET in ageing and Alzheimer's disease.

Authors:  Clifford R Jack; Heather J Wiste; Christopher G Schwarz; Val J Lowe; Matthew L Senjem; Prashanthi Vemuri; Stephen D Weigand; Terry M Therneau; Dave S Knopman; Jeffrey L Gunter; David T Jones; Jonathan Graff-Radford; Kejal Kantarci; Rosebud O Roberts; Michelle M Mielke; Mary M Machulda; Ronald C Petersen
Journal:  Brain       Date:  2018-05-01       Impact factor: 13.501

9.  Flortaucipir tau PET imaging in semantic variant primary progressive aphasia.

Authors:  Sara J Makaretz; Megan Quimby; Jessica Collins; Nikos Makris; Scott McGinnis; Aaron Schultz; Neil Vasdev; Keith A Johnson; Bradford C Dickerson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-10-06       Impact factor: 10.154

10.  Longitudinal white matter change in frontotemporal dementia subtypes and sporadic late onset Alzheimer's disease.

Authors:  Fanny M Elahi; Gabe Marx; Yann Cobigo; Adam M Staffaroni; John Kornak; Duygu Tosun; Adam L Boxer; Joel H Kramer; Bruce L Miller; Howard J Rosen
Journal:  Neuroimage Clin       Date:  2017-09-14       Impact factor: 4.881

View more
  1 in total

1.  Influence of common reference regions on regional tau patterns in cross-sectional and longitudinal [18F]-AV-1451 PET data.

Authors:  Christina B Young; Susan M Landau; Theresa M Harrison; Kathleen L Poston; Elizabeth C Mormino
Journal:  Neuroimage       Date:  2021-09-03       Impact factor: 6.556

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.